AVTR: Avantor, Inc. - Summary | Jitta

Avantor, Inc.

NYSE:AVTR

Price
$37.48
Loss Chance
43.9%
5.51JITTA SCORE
12.63%Over Jitta Line
Jitta Ranking
21 / 1,042
521 / 4,597
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (72)
Recent Business Performance (81)
Financial Strength (53)
Return to Shareholders (28)
Competitive Advantage (74)
Jitta Signs
Recent Business PerformanceEarning Growth Last Year
SG&A to SalesDecreasing Every Year
Recent IPOLess than 3 years
Debt LevelVery High Long Term Debt
Key Stats
Jitta Score
Jitta Line
5.51
12.63%
2.24
353.92%
Life Sciences Tools and Services
7.15
148.21%
6.99
142.42%
6.52
77.54%
COMPANY DESCRIPTION
Avantor, Inc. provides products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, and clinical trial kits. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Avantor, Inc. was founded in 1904 and is headquartered in Radnor, Pennsylvania.